CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Short Interest Update

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) was the target of a significant decline in short interest during the month of October. As of October 31st, there was short interest totalling 7,500 shares, a decline of 11.8% from the October 15th total of 8,500 shares. Based on an average daily trading volume, of 280,100 shares, the short-interest ratio is currently 0.0 days.

CNBX Pharmaceuticals Price Performance

Shares of OTCMKTS:CNBX remained flat at $0.01 during trading on Friday. 838 shares of the stock were exchanged, compared to its average volume of 187,155. CNBX Pharmaceuticals has a twelve month low of $0.01 and a twelve month high of $0.02. The firm’s fifty day moving average is $0.01 and its two-hundred day moving average is $0.01.

CNBX Pharmaceuticals Company Profile

CNBX Pharmaceuticals Inc, a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome.